major-depressive-disorder

Documents about major-depressive-disorder

• Major Depressive Disorder Study In Adults#828130ClinicalTrials.gov
• An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder#846183ClinicalTrials.gov
• Adjunctive Probiotic Therapy in Major Depressive Disorder (ProMOOD)#683101ClinicalTrials.gov
• Improving Health Care in Major Depressive Disorder#833976ClinicalTrials.gov
• MRS and Medication Response: A Pilot Study#916018ClinicalTrials.gov
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder#856211ClinicalTrials.gov
• Light Therapy to Improve Symptoms in Pregnant Women With Major Depressive Disorder#866693ClinicalTrials.gov
• Multicomponent Yoga Intervention for Major Depressive Disorder#811180ClinicalTrials.gov
• Major Depressive Disorder In The Elderly#845800ClinicalTrials.gov
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder#810083ClinicalTrials.gov
• Study Comparing Remission Rates, in Patients With Major Depressive Disorder (MDD)#802672ClinicalTrials.gov
• Action Tendencies and Prognosis in Major Depressive Disorder#868779ClinicalTrials.gov
• Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder#844770ClinicalTrials.gov
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder#967545ClinicalTrials.gov
• EEG Biomarkers for Predicting Response to Antidepressant Therapy#827439ClinicalTrials.gov
• St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety#804462ClinicalTrials.gov
• Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder#896900ClinicalTrials.gov
• Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder#802609ClinicalTrials.gov
• Escitalopram in Adult Patients With Major Depressive Disorder#811482ClinicalTrials.gov
• A Study in Patients With Major Depressive Disorder#864606ClinicalTrials.gov
• Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression#894893ClinicalTrials.gov
• Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder#982229ClinicalTrials.gov
• Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.#837871ClinicalTrials.gov
• Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder#847255ClinicalTrials.gov
• Effectiveness of Cariprazine Monotherapy for Treatment of Major Depressive Disorder#847420ClinicalTrials.gov
• SA4503 8-Week Study in Major Depressive Disorder (MDD)#855890ClinicalTrials.gov
• NMDA Modulation in Major Depressive Disorder in Late- Life#882242ClinicalTrials.gov
• A Safety Study in Participants With Major Depressive Disorder#897863ClinicalTrials.gov
• Magnesium Bisglycinate in Major Depressive Disorder#917972ClinicalTrials.gov
• Major Depressive Disorder With Mixed Features#968028ClinicalTrials.gov
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy#847825ClinicalTrials.gov
• Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder#906923ClinicalTrials.gov
• A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder#912968ClinicalTrials.gov
• Insulin Resistance in Patients With Major Depression#623474ClinicalTrials.gov
• Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder#849292ClinicalTrials.gov
• Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder#981439ClinicalTrials.gov
• Comparison of Two tDCS Protocols for the Treatment of Major Depressive Disorder#851944ClinicalTrials.gov
• Cultural Adaptation of EMDR for Major Depressive Disorder and Compaire Its Online and Face-to-Face Testing#860816ClinicalTrials.gov
• Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)#847609ClinicalTrials.gov
• A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder#651216ClinicalTrials.gov
• D-cycloserine for Major Depressive Disorder#812425ClinicalTrials.gov
• Major Depressive Disorder With Mixed Features - Extension#857495ClinicalTrials.gov
• Double-Blind Treatment of Major Depressive Disorder With Vilazodone#860276ClinicalTrials.gov
• Multimodal Pharmacological Study of Clinical Cohorts for Major Depressive Disorder#868742ClinicalTrials.gov
• Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)#895043ClinicalTrials.gov
• Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder#907750ClinicalTrials.gov
• Effects of Electroacupuncture With Different Frequencies for Major Depressive Disorder#1008456ClinicalTrials.gov
• A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder#859923ClinicalTrials.gov
• Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability#968222ClinicalTrials.gov
• Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder#862505ClinicalTrials.gov

Related topics